Global Medicinal Radiocompounds Market Research Report 2025(Status and Outlook)

March 2025 | 231 pages | ID: GAC5E5A8BB1EEN
Bosson Research

Abstracts

Report Overview

Medicinal Radiocompounds refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Medicinal Radiocompounds are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

This report provides a deep insight into the global Medicinal Radiocompounds market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Medicinal Radiocompounds Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Medicinal Radiocompounds market in any manner.

Global Medicinal Radiocompounds Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Bracco Imaging

Bayer

Cardinal Health

Curium Pharma

Novartis

Lantheus

Acrotech Biopharma

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

SIEMENS

Dongcheng

Market Segmentation (by Type)

Technetium 99

Fluorine 18

Other

Market Segmentation (by Application)

Oncology

Cardiology

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Medicinal Radiocompounds Market
• Overview of the regional outlook of the Medicinal Radiocompounds Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Medicinal Radiocompounds Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Medicinal Radiocompounds
1.2 Key Market Segments
  1.2.1 Medicinal Radiocompounds Segment by Type
  1.2.2 Medicinal Radiocompounds Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL MEDICINAL RADIOCOMPOUNDS MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Medicinal Radiocompounds Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Medicinal Radiocompounds Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL MEDICINAL RADIOCOMPOUNDS MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Medicinal Radiocompounds Product Life Cycle
3.3 Global Medicinal Radiocompounds Sales by Manufacturers (2020-2025)
3.4 Global Medicinal Radiocompounds Revenue Market Share by Manufacturers (2020-2025)
3.5 Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Medicinal Radiocompounds Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Medicinal Radiocompounds Manufacturing Sites, Area Served, Product Type
3.8 Medicinal Radiocompounds Market Competitive Situation and Trends
  3.8.1 Medicinal Radiocompounds Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Medicinal Radiocompounds Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MEDICINAL RADIOCOMPOUNDS INDUSTRY CHAIN ANALYSIS

4.1 Medicinal Radiocompounds Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MEDICINAL RADIOCOMPOUNDS MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Medicinal Radiocompounds Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Medicinal Radiocompounds Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL MEDICINAL RADIOCOMPOUNDS MARKET BY REGION

6.1 Global Medicinal Radiocompounds Market Size by Region
  6.1.1 Global Medicinal Radiocompounds Market Size by Region
  6.1.2 Global Medicinal Radiocompounds Market Size Market Share by Region
6.2 Global Medicinal Radiocompounds Sales by Region
  6.2.1 Global Medicinal Radiocompounds Sales by Region
  6.2.2 Global Medicinal Radiocompounds Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Medicinal Radiocompounds Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Medicinal Radiocompounds Market Size by Type
7.3 North America Medicinal Radiocompounds Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Medicinal Radiocompounds Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Medicinal Radiocompounds Market Size by Type
8.3 Europe Medicinal Radiocompounds Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Medicinal Radiocompounds Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Medicinal Radiocompounds Market Size by Type
9.3 Asia-Pacific Medicinal Radiocompounds Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Medicinal Radiocompounds Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Medicinal Radiocompounds Market Size by Type
10.3 South America Medicinal Radiocompounds Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Medicinal Radiocompounds Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Medicinal Radiocompounds Market Size by Type
11.3 Middle East and Africa Medicinal Radiocompounds Market Size by Application

12 MEDICINAL RADIOCOMPOUNDS MARKET PRODUCTION BY REGION

12.1 Global Production of Medicinal Radiocompounds by Region(2020-2025)
12.2 Global Medicinal Radiocompounds Revenue Market Share by Region (2020-2025)
12.3 Global Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Medicinal Radiocompounds Production
  12.4.1 North America Medicinal Radiocompounds Production Growth Rate (2020-2025)
  12.4.2 North America Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Medicinal Radiocompounds Production
  12.5.1 Europe Medicinal Radiocompounds Production Growth Rate (2020-2025)
  12.5.2 Europe Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Medicinal Radiocompounds Production (2020-2025)
  12.6.1 Japan Medicinal Radiocompounds Production Growth Rate (2020-2025)
  12.6.2 Japan Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Medicinal Radiocompounds Production (2020-2025)
  12.7.1 China Medicinal Radiocompounds Production Growth Rate (2020-2025)
  12.7.2 China Medicinal Radiocompounds Production, Revenue, Price and Gross Margin (2020-2025)

13 MEDICINAL RADIOCOMPOUNDS MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Medicinal Radiocompounds Sales Market Share by Type (2020-2033)
13.3 Global Medicinal Radiocompounds Market Size Market Share by Type (2020-2033)
13.4 Global Medicinal Radiocompounds Price by Type (2020-2033)

14 MEDICINAL RADIOCOMPOUNDS MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Medicinal Radiocompounds Market Sales by Application (2020-2033)
14.3 Global Medicinal Radiocompounds Market Size (M USD) by Application (2020-2033)
14.4 Global Medicinal Radiocompounds Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Bracco Imaging
  15.1.1 Bracco Imaging Basic Information
  15.1.2 Bracco Imaging Medicinal Radiocompounds Product Overview
  15.1.3 Bracco Imaging Medicinal Radiocompounds Product Market Performance
  15.1.4 Bracco Imaging Business Overview
  15.1.5 Bracco Imaging SWOT Analysis
  15.1.6 Bracco Imaging Recent Developments
15.2 Bayer
  15.2.1 Bayer Basic Information
  15.2.2 Bayer Medicinal Radiocompounds Product Overview
  15.2.3 Bayer Medicinal Radiocompounds Product Market Performance
  15.2.4 Bayer Business Overview
  15.2.5 Bayer SWOT Analysis
  15.2.6 Bayer Recent Developments
15.3 Cardinal Health
  15.3.1 Cardinal Health Basic Information
  15.3.2 Cardinal Health Medicinal Radiocompounds Product Overview
  15.3.3 Cardinal Health Medicinal Radiocompounds Product Market Performance
  15.3.4 Cardinal Health Business Overview
  15.3.5 Cardinal Health SWOT Analysis
  15.3.6 Cardinal Health Recent Developments
15.4 Curium Pharma
  15.4.1 Curium Pharma Basic Information
  15.4.2 Curium Pharma Medicinal Radiocompounds Product Overview
  15.4.3 Curium Pharma Medicinal Radiocompounds Product Market Performance
  15.4.4 Curium Pharma Business Overview
  15.4.5 Curium Pharma Recent Developments
15.5 Novartis
  15.5.1 Novartis Basic Information
  15.5.2 Novartis Medicinal Radiocompounds Product Overview
  15.5.3 Novartis Medicinal Radiocompounds Product Market Performance
  15.5.4 Novartis Business Overview
  15.5.5 Novartis Recent Developments
15.6 Lantheus
  15.6.1 Lantheus Basic Information
  15.6.2 Lantheus Medicinal Radiocompounds Product Overview
  15.6.3 Lantheus Medicinal Radiocompounds Product Market Performance
  15.6.4 Lantheus Business Overview
  15.6.5 Lantheus Recent Developments
15.7 Acrotech Biopharma
  15.7.1 Acrotech Biopharma Basic Information
  15.7.2 Acrotech Biopharma Medicinal Radiocompounds Product Overview
  15.7.3 Acrotech Biopharma Medicinal Radiocompounds Product Market Performance
  15.7.4 Acrotech Biopharma Business Overview
  15.7.5 Acrotech Biopharma Recent Developments
15.8 GE Healthcare
  15.8.1 GE Healthcare Basic Information
  15.8.2 GE Healthcare Medicinal Radiocompounds Product Overview
  15.8.3 GE Healthcare Medicinal Radiocompounds Product Market Performance
  15.8.4 GE Healthcare Business Overview
  15.8.5 GE Healthcare Recent Developments
15.9 China Isotope and Radiation
  15.9.1 China Isotope and Radiation Basic Information
  15.9.2 China Isotope and Radiation Medicinal Radiocompounds Product Overview
  15.9.3 China Isotope and Radiation Medicinal Radiocompounds Product Market Performance
  15.9.4 China Isotope and Radiation Business Overview
  15.9.5 China Isotope and Radiation Recent Developments
15.10 Jubilant Pharma
  15.10.1 Jubilant Pharma Basic Information
  15.10.2 Jubilant Pharma Medicinal Radiocompounds Product Overview
  15.10.3 Jubilant Pharma Medicinal Radiocompounds Product Market Performance
  15.10.4 Jubilant Pharma Business Overview
  15.10.5 Jubilant Pharma Recent Developments
15.11 Eli Lilly
  15.11.1 Eli Lilly Basic Information
  15.11.2 Eli Lilly Medicinal Radiocompounds Product Overview
  15.11.3 Eli Lilly Medicinal Radiocompounds Product Market Performance
  15.11.4 Eli Lilly Business Overview
  15.11.5 Eli Lilly Recent Developments
15.12 SIEMENS
  15.12.1 SIEMENS Basic Information
  15.12.2 SIEMENS Medicinal Radiocompounds Product Overview
  15.12.3 SIEMENS Medicinal Radiocompounds Product Market Performance
  15.12.4 SIEMENS Business Overview
  15.12.5 SIEMENS Recent Developments
15.13 Dongcheng
  15.13.1 Dongcheng Basic Information
  15.13.2 Dongcheng Medicinal Radiocompounds Product Overview
  15.13.3 Dongcheng Medicinal Radiocompounds Product Market Performance
  15.13.4 Dongcheng Business Overview
  15.13.5 Dongcheng Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Medicinal Radiocompounds Market Size by Type (M USD)
Table 4. Global Medicinal Radiocompounds Market Size by Application (M USD)
Table 5. Medicinal Radiocompounds Market Size Comparison by Region (M USD)
Table 6. Global Medicinal Radiocompounds Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Medicinal Radiocompounds Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Medicinal Radiocompounds Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Medicinal Radiocompounds Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medicinal Radiocompounds as of 2024)
Table 11. Global Market Medicinal Radiocompounds Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Medicinal Radiocompounds Manufacturing Sites and Area Served
Table 13. Manufacturers Medicinal Radiocompounds Product Type
Table 14. Global Medicinal Radiocompounds Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Medicinal Radiocompounds Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Medicinal Radiocompounds Market Size Comparison by Region (M USD)
Table 26. Global Medicinal Radiocompounds Market Size by Region (2020-2033) & (M USD)
Table 27. Global Medicinal Radiocompounds Market Size Market Share by Region (2020-2033)
Table 28. Global Medicinal Radiocompounds Sales by Region (2020-2033) & (K MT)
Table 29. Global Medicinal Radiocompounds Sales Market Share by Region (2020-2033)
Table 30. North America Medicinal Radiocompounds Market Size by Country (2020-2033) & (M USD)
Table 31. North America Medicinal Radiocompounds Sales by Country (2020-2033) & (K MT)
Table 32. North America Medicinal Radiocompounds Sales by Type (K MT)
Table 33. North America Medicinal Radiocompounds Market Size by Type (M USD)
Table 34. North America Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 35. North America Medicinal Radiocompounds Market Size (M USD) by Type (2020-2033)
Table 36. North America Medicinal Radiocompounds Sales by Application (K MT)
Table 37. North America Medicinal Radiocompounds Market Size by Application (M USD)
Table 38. North America Medicinal Radiocompounds Sales (K MT) by Application (2020-2033)
Table 39. North America Medicinal Radiocompounds Market Size (M USD) by Application (2020-2033)
Table 40. Europe Medicinal Radiocompounds Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Medicinal Radiocompounds Sales by Country (2020-2033) & (K MT)
Table 42. Europe Medicinal Radiocompounds Sales by Type (K MT)
Table 43. Europe Medicinal Radiocompounds Market Size by Type (M USD)
Table 44. Europe Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 45. Europe Medicinal Radiocompounds Market Size (M USD) by Type (2020-2033)
Table 46. Europe Medicinal Radiocompounds Sales by Application (K MT)
Table 47. Europe Medicinal Radiocompounds Market Size by Application (M USD)
Table 48. Europe Medicinal Radiocompounds Sales (K MT) by Application (2020-2033)
Table 49. Europe Medicinal Radiocompounds Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Medicinal Radiocompounds Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Medicinal Radiocompounds Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Medicinal Radiocompounds Sales by Type (K MT)
Table 53. Asia-Pacific Medicinal Radiocompounds Market Size by Type (M USD)
Table 54. Asia-Pacific Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Medicinal Radiocompounds Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Medicinal Radiocompounds Sales by Application (K MT)
Table 57. Asia-Pacific Medicinal Radiocompounds Market Size by Application (M USD)
Table 58. Asia-Pacific Medicinal Radiocompounds Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Medicinal Radiocompounds Market Size (M USD) by Application (2020-2025)
Table 60. South America Medicinal Radiocompounds Market Size by Country (2020-2033) & (M USD)
Table 61. South America Medicinal Radiocompounds Sales by Country (2020-2033) & (K MT)
Table 62. South America Medicinal Radiocompounds Sales by Type (K MT)
Table 63. South America Medicinal Radiocompounds Market Size by Type (M USD)
Table 64. South America Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 65. South America Medicinal Radiocompounds Market Size (M USD) by Type (2020-2033)
Table 66. South America Medicinal Radiocompounds Sales by Application (K MT)
Table 67. South America Medicinal Radiocompounds Market Size by Application (M USD)
Table 68. South America Medicinal Radiocompounds Sales (K MT) by Application (2020-2033)
Table 69. South America Medicinal Radiocompounds Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Medicinal Radiocompounds Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Medicinal Radiocompounds Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Medicinal Radiocompounds Sales by Type (K MT)
Table 73. Middle East and Africa Medicinal Radiocompounds Market Size by Type (M USD)
Table 74. Middle East and Africa Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Medicinal Radiocompounds Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Medicinal Radiocompounds Sales by Application (K MT)
Table 77. Middle East and Africa Medicinal Radiocompounds Market Size by Application (M USD)
Table 78. Middle East and Africa Medicinal Radiocompounds Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Medicinal Radiocompounds Market Size (M USD) by Application (2020-2033)
Table 80. Global Medicinal Radiocompounds Production (K MT) by Region(2020-2025)
Table 81. Global Medicinal Radiocompounds Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Medicinal Radiocompounds Revenue Market Share by Region (2020-2025)
Table 83. Global Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Medicinal Radiocompounds Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Medicinal Radiocompounds Sales by Type (K MT)
Table 89. Global Medicinal Radiocompounds Market Size by Type (M USD)
Table 90. Global Medicinal Radiocompounds Sales (K MT) by Type (2020-2033)
Table 91. Global Medicinal Radiocompounds Sales Market Share by Type (2020-2033)
Table 92. Global Medicinal Radiocompounds Market Size (M USD) by Type (2020-2033)
Table 93. Global Medicinal Radiocompounds Market Size Share by Type (2020-2033)
Table 94. Global Medicinal Radiocompounds Sales (K MT) by Application
Table 95. Global Medicinal Radiocompounds Market Size by Application(M USD)
Table 96. Global Medicinal Radiocompounds Sales by Application (2020-2033) & (K MT)
Table 97. Global Medicinal Radiocompounds Sales Market Share by Application (2020-2033)
Table 98. Global Medicinal Radiocompounds Market Size by Application (2020-2033) & (M USD)
Table 99. Global Medicinal Radiocompounds Market Share by Application (2020-2033)
Table 100. Global Medicinal Radiocompounds Sales Growth Rate by Application (2020-2033)
Table 101. Bracco Imaging Basic Information
Table 102. Bracco Imaging Medicinal Radiocompounds Product Overview
Table 103. Bracco Imaging Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Bracco Imaging Business Overview
Table 105. Bracco Imaging SWOT Analysis
Table 106. Bracco Imaging Recent Developments
Table 107. Bayer Basic Information
Table 108. Bayer Medicinal Radiocompounds Product Overview
Table 109. Bayer Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. Bayer Business Overview
Table 111. Bayer SWOT Analysis
Table 112. Bayer Recent Developments
Table 113. Cardinal Health Basic Information
Table 114. Cardinal Health Medicinal Radiocompounds Product Overview
Table 115. Cardinal Health Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Cardinal Health Business Overview
Table 117. Cardinal Health SWOT Analysis
Table 118. Cardinal Health Recent Developments
Table 119. Curium Pharma Basic Information
Table 120. Curium Pharma Medicinal Radiocompounds Product Overview
Table 121. Curium Pharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Curium Pharma Business Overview
Table 123. Curium Pharma Recent Developments
Table 124. Novartis Basic Information
Table 125. Novartis Medicinal Radiocompounds Product Overview
Table 126. Novartis Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Novartis Business Overview
Table 128. Novartis Recent Developments
Table 129. Lantheus Basic Information
Table 130. Lantheus Medicinal Radiocompounds Product Overview
Table 131. Lantheus Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. Lantheus Business Overview
Table 133. Lantheus Recent Developments
Table 134. Acrotech Biopharma Basic Information
Table 135. Acrotech Biopharma Medicinal Radiocompounds Product Overview
Table 136. Acrotech Biopharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Acrotech Biopharma Business Overview
Table 138. Acrotech Biopharma Recent Developments
Table 139. GE Healthcare Basic Information
Table 140. GE Healthcare Medicinal Radiocompounds Product Overview
Table 141. GE Healthcare Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. GE Healthcare Business Overview
Table 143. GE Healthcare Recent Developments
Table 144. China Isotope and Radiation Basic Information
Table 145. China Isotope and Radiation Medicinal Radiocompounds Product Overview
Table 146. China Isotope and Radiation Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. China Isotope and Radiation Business Overview
Table 148. China Isotope and Radiation Recent Developments
Table 149. Jubilant Pharma Basic Information
Table 150. Jubilant Pharma Medicinal Radiocompounds Product Overview
Table 151. Jubilant Pharma Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. Jubilant Pharma Business Overview
Table 153. Jubilant Pharma Recent Developments
Table 154. Eli Lilly Basic Information
Table 155. Eli Lilly Medicinal Radiocompounds Product Overview
Table 156. Eli Lilly Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Eli Lilly Business Overview
Table 158. Eli Lilly Recent Developments
Table 159. SIEMENS Basic Information
Table 160. SIEMENS Medicinal Radiocompounds Product Overview
Table 161. SIEMENS Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 162. SIEMENS Business Overview
Table 163. SIEMENS Recent Developments
Table 164. Dongcheng Basic Information
Table 165. Dongcheng Medicinal Radiocompounds Product Overview
Table 166. Dongcheng Medicinal Radiocompounds Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 167. Dongcheng Business Overview
Table 168. Dongcheng Recent Developments
List of Figures
Figure 1. Product Picture of Medicinal Radiocompounds
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Medicinal Radiocompounds Market Size (M USD), 2024-2033
Figure 5. Global Medicinal Radiocompounds Market Size (M USD) (2020-2033)
Figure 6. Global Medicinal Radiocompounds Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Medicinal Radiocompounds Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Medicinal Radiocompounds Product Life Cycle
Figure 13. Medicinal Radiocompounds Sales Share by Manufacturers in 2024
Figure 14. Global Medicinal Radiocompounds Revenue Share by Manufacturers in 2024
Figure 15. Medicinal Radiocompounds Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Medicinal Radiocompounds Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Medicinal Radiocompounds Revenue in 2024
Figure 18. Industry Chain Map of Medicinal Radiocompounds
Figure 19. Global Medicinal Radiocompounds Market PEST Analysis
Figure 20. Global Medicinal Radiocompounds Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Medicinal Radiocompounds Market Size by Region
Figure 27. Global Medicinal Radiocompounds Market Size Market Share by Region (2020-2033)
Figure 28. Global Medicinal Radiocompounds Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Medicinal Radiocompounds Market Size (M USD) by Country
Figure 33. USA Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Medicinal Radiocompounds Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Medicinal Radiocompounds Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Medicinal Radiocompounds Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Medicinal Radiocompounds Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Medicinal Radiocompounds Market Size (M USD)by Type
Figure 40. North America Medicinal Radiocompounds Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Medicinal Radiocompounds Market Size (M USD) by Country
Figure 45. Germany Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Medicinal Radiocompounds Market Size (M USD) by Type
Figure 56. Europe Medicinal Radiocompounds Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Medicinal Radiocompounds Market Size (M USD) by Country
Figure 61. China Medicinal Radiocompounds Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Medicinal Radiocompounds Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Medicinal Radiocompounds Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Medicinal Radiocompounds Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Medicinal Radiocompounds Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Medicinal Radiocompounds Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Medicinal Radiocompounds Market Size (M USD) by Type
Figure 72. Asia-Pacific Medicinal Radiocompounds Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Medicinal Radiocompounds Market Size (M USD) by Country
Figure 77. Brazil Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Medicinal Radiocompounds Market Size (M USD) by Type
Figure 84. South America Medicinal Radiocompounds Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Medicinal Radiocompounds Market Size (M USD) by Country
Figure 89. Saudi Arabia Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Medicinal Radiocompounds Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Medicinal Radiocompounds Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Medicinal Radiocompounds Market Size (M USD) by Type
Figure 100. Middle East and Africa Medicinal Radiocompounds Market Size (M USD) by Application
Figure 101. Global Medicinal Radiocompounds Production Market Share by Region (2020-2025)
Figure 102. North America Medicinal Radiocompounds Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Medicinal Radiocompounds Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Medicinal Radiocompounds Production (K MT) Growth Rate (2020-2025)
Figure 105. China Medicinal Radiocompounds Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Medicinal Radiocompounds Market Size by Type (M USD)
Figure 108. Sales Market Share of Medicinal Radiocompounds by Type (2020-2033)
Figure 109. Sales Market Share of Medicinal Radiocompounds by Type in 2024
Figure 110. Market Size Share of Medicinal Radiocompounds by Type (2020-2033)
Figure 111. Market Size Share of Medicinal Radiocompounds by Type in 2024
Figure 112. Global Medicinal Radiocompounds Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Medicinal Radiocompounds Market Size by Application(M USD)
Figure 115. Global Medicinal Radiocompounds Market Share by Application
Figure 116. Global Medicinal Radiocompounds Sales Market Share by Application (2020-2033)
Figure 117. Global Medicinal Radiocompounds Sales Market Share by Application in 2024
Figure 118. Global Medicinal Radiocompounds Market Share by Application (2020-2033)
Figure 119. Global Medicinal Radiocompounds Market Share by Application in 2024
Figure 120. Global Medicinal Radiocompounds Sales Growth Rate by Application (2020-2033)